Get the Stockscreener App
182.22
0.19%
-0.3434
Vaneck Biotech Etf stock is traded at $182.22, with a volume of 8,613.
It is down -0.19% in the last 24 hours and down -7.64% over the past month.
See More
Previous Close:
$182.56
Open:
$181.03
24h Volume:
8,613
Relative Volume:
1.23
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.90%
1M Performance:
-7.64%
6M Performance:
+10.93%
1Y Performance:
+11.88%
1-Day Range:
$180.47
$182.78
1-Week Range:
$180.47
$185.04
52-Week Range:
$135.34
$202.91
Vaneck Biotech Etf Stock (BBH) Company Profile
Name
Vaneck Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare BBH vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
182.22 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
323.18 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
State Street Spdr S P 500 Etf Trust
|
653.18 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
656.23 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
263.51 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
583.98 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf Stock (BBH) Latest News
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - sharewise.com
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom - Bitget
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - The Globe and Mail
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
How AI Is Reshaping Drug Discovery and Healthcare Investing - VanEck
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps - Bitget
Why Is Vertex Pharmaceuticals Stock Soaring Tuesday?Vertex Pharmaceuticals (NASDAQ:VRTX) - Benzinga
Is Investing in the VanEck Biotech ETF (BBH) a Good Choice? - Bitget
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance Singapore
How to Buy iShares Biotechnology ETF (IBB) - The Motley Fool
How to Invest in VanEck Biotech ETF (BBH) - The Motley Fool
True Market-Cap Exposure to Communication Services - VanEck
The top performing pharma and biotech stocks as group sees resurgence (PJP:NYSEARCA) - Seeking Alpha
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
How AI Is Reshaping Drug Discovery And Healthcare Investing - Seeking Alpha
Best Biotech ETFs to Buy in 2026 - The Motley Fool
Where To Invest $100,000: Japan Stocks, AI, Baseball Cards - Bloomberg.com
Moderna’s rally ripples through biotech and health care ETFs - MSN
Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize? - Seeking Alpha
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
December Market Recap: Innovation Matures, Constraints Tighten, Money Evolves - VanEck
Nvidia–Eli Lilly Tie-Up Shows Why AI Drug Discovery Is The Next ETF Battleground - Benzinga
Precious Metals Define Commodity Performance in 2025 - VanEck
IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns - Seeking Alpha
Why VanEck Morningstar International Moat ETF stock is upgraded to buyJuly 2025 Macro Moves & Free Community Consensus Stock Picks - ulpravda.ru
Healthcare Stocks In Focus: Assessing The Outlook For 2026 - Seeking Alpha
As Gold Soars, Opportunity Lies in ‘Better, Not Bigger’ Mining Acquisitions - VanEck
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 16.5% - Defense World
How to Buy Gilead Sciences Stock (GILD) - The Motley Fool
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge (NASDAQ:BIIB) - Seeking Alpha
VanEck Biotech ETF declares annual distribution of $0.9565 - MSN
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Day by day downgrades VanEck ETF TrustVanEck Biotech ETF (BBH) - MSN
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
VanEck Mid-December 2025 Bitcoin ChainCheck - VanEck
VanEck Announces Year-End Distributions for VanEck Equity ETFs - Crypto Reporter
Plan for 2026: Predictions from Our Portfolio Managers - VanEck
The Next Phase of Retail: How Consumer Behavior and Technology Are Shaping the Industry - VanEck
Defense Start-ups Galvanize a Once Sleepy Sector - VanEck
5 Best ETFs for Tax-Loss Harvesting | Investing | U.S. News - US News Money
November Market Recap: AI Adoption Surges & Tight Liquidity Creates Opportunity - VanEck
Vaneck Biotech Etf Stock (BBH) Financials Data
There is no financial data for Vaneck Biotech Etf (BBH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.55%
1.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):